Thalassaemia treatment gets EU approval
New data from Parkinson’s disease trial
Restoring the “longevity protein”
Positive topline results from phase 2 recurrent ovarian cancer trial
Haemodialysis treatment sees “transformative” results
New immunotherapy targets common cancer mutation
Synaffix and Qurient Therapeutics to develop dual-payload ADC
Tagomics publishes new approach to genome-wide epigenomic profiling
Fast-acting actin explains the survival of cancer cells
Phase 2 data for chronic inducible urticaria
Base to Base biotech podcast 28: CTPS1 and ocular therapeutics
Positive results from phase 1 Huntington’s disease trial